Database guide last
updated July 20, 2023

Copyright 2023,
Wolters Kluwer Health

Northern Light's conference abstract and posters collection provides a treasure trove of life sciences research information, often several years before that information is published in industry or academic journals. Search a full-text index of:

• More than 1,550,000 abstracts and posters
• From 1,600 life sciences industry conferences
• Conferences from 2010-present
• New conferences added as the abstracts are posted

The limit of databases that you can select for a multi-file search session is based upon database segments rather than actual databases. The Ovid multi-file segment limit is set at 120 to avoid impacting your search sessions. This database includes 10 segments.

This database is updated online weekly.

Quotation marks can be used to retrieve records that contain literal strings, when the string includes special characters, such as a forward slash (/).

Quotation marks can also be used to retrieve records that contain numbers that may otherwise be confused for earlier searches. In the example, a search for 3.vo would limit the string from your third search in your search history to the volume field. By including the number in quotation marks, the search will retrieve documents with a 3 in the volume number.

The Ovid search engine applies so called "run-time stopword processing". This means the search engine on the fly ignores the stopwords: and, as, by, for, from, in, is, of, on, that, the, this, to, was, were & with.

Therefore a search: at risk for diabetes.ti will also find: at risk of diabetes. The distance of one word in between is kept, but the stopword "for" is ignored.

Will limit to those documents with a Type of 'abstract'.

Will limit to those documents with Types of 'abstract' and 'poster'.

The cell receptor entity discussed in the source document.

The clinical trial phase discussed in the source document.

The medical devices discussed in the source document.

Will limit to those documents with a Type of 'poster'.

The therapeutic areas discussed in the source document.

• Tree
• Permuted Index
• Scope Notes
• Explode
• Classification Codes
• Subheadings

Accession Number:
  PE20180619040000900
Title:
  In Vitro Resistance And Gas Transfer Properties of the Pulmonary Assist Device, an Ambulatory ECMO Oxygenator Designed For Destination Therapy
Author Affiliation:
  Caitlin T Demarest - Columbia University
  David J Skoog - Carnegie Mellon University
  Matthew D Bacchetta - Columbia University
  Keith E Cook - Carnegie Mellon University
Author:
  Caitlin T Demarest; David J Skoog; Matthew D Bacchetta; Keith E Cook
Primary Author:
  Caitlin T Demarest
Conference Name:
  American Association for Thoracic Surgery Annual Meeting 2018
Conference Sponsor:
  American Association for Thoracic Surgery (AATS)
Conference Start Date:
  28-Apr-2018
Conference End Date:
  01-May-2018
Conference Location:
  San Diego, CA, US
Abstract URL:
  https://discovery.northernlight....
Abstract:
  The PAD exceeded both our gas exchange and resistance goals. Its current resistance is approximately 25-50% of commercially available oxygenators, 
  and two modules in parallel will have a resistance approaching the native lung. This is critical to our destination therapy concept for a number 
  of reasons: i) a lower resistance through the device will result in less blood activation and damage, ii) in a pumped setting, the pump can be set 
  on lower RPMs to generate the same flows, thereby decreasing pump-induced blood damage and activation, and iii) the device
  Copyright © 2021, Northern Light Group, LLC. All Rights Reserved.
Abstract Number:
  T18
Human Anatomy:
  Lung [3]
Publication Type:
  Abstract
Year:
  2018
Update Code:
  20211230
  	  

Accession Number:
  PE20180223460004970
Title:
  The Impact of Persistence of Cytogenetic Abnormalities Pre-Transplantation In AML And MDS - a Single UK Centre 
  Retrospective Review
Author Affiliation:
  S Sivakumaran - Le Centre Hospitalier des Pays de Morlaix
  A Bloor - Le Centre Hospitalier des Pays de Morlaix
  J Murray - Le Centre Hospitalier des Pays de Morlaix
  S Kulkarni - Le Centre Hospitalier des Pays de Morlaix
  A-M Sjursen - Le Centre Hospitalier des Pays de Morlaix
  M Dennis - Le Centre Hospitalier des Pays de Morlaix
Author:
  S Sivakumaran; A Bloor; J Murray; S Kulkarni; A-M Sjursen; M Dennis
Primary Author:
  S Sivakumaran
Conference Name:
  British Society for Haematology Annual Scientific Meeting 2017
Conference Sponsor:
  British Society for Haematology (BSH)
Conference Start Date:
  27-Mar-2017
Abstract URL:
  https://discovery.northernlight....
Abstract:
  The group with persisting cytogenetic abnormalities had a significantly shorter period of time relapse-free when compared to 
  those whose abnormalities resolved pre-transplant, with a mean of 1704 days, compared to 2932 days (p = 0.023).
  Longer time between pre-transplant cytogenetic assessment and transplant could, in theory, allow time for molecular relapse 
  prior to transplant and misclassification in our analysis, however there was no significant difference in the median time from bone 
  marrow ascertainment to transplant (30 days in both groups, p = 0.22). Our findings show that although persistent cytogenetic 
  abnormalities pre-transplant are associated with a shorter period of time relapse-free, an important proportion have good 
  outcomes, with 40.9% alive and disease free 2 years post transplant.
  Copyright © 2018, Northern Light Group, LLC. All Rights Reserved.
Cell:
  Stem Cells [1]
Disease:
  Chromosome Aberrations [5], Myelodysplastic Syndromes [1]
Pharma Research Scenario:
  Chromosome Aberrations is related to Myelodysplastic Syndromes. [8]
  Chromosome Aberrations is related to Stem Cells. [4]
Publication Type:
  Abstract
Year:
  2017
Update Code:
  20180225
  	  

Copyright 1996-2020 by Northern Light Group, LLC.